Literature DB >> 19103726

Mastering emasculation.

Richard J Wassersug1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19103726     DOI： 10.1200/JCO.2008.20.1947

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Eroticization as a factor influencing erectile dysfunction treatment effectiveness.

Authors:  K C Kukula; R A Jackowich; R J Wassersug
Journal:  Int J Impot Res       Date:  2013-07-04       Impact factor: 2.896

Review 2.  Quality of life issues in men undergoing androgen deprivation therapy: a review.

Authors:  Rowan G Casey; Niall M Corcoran; S Larry Goldenberg
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

Review 3.  Androgen receptors beyond prostate cancer: an old marker as a new target.

Authors:  Javier Munoz; Jennifer J Wheler; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-01-20

Review 4.  Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction.

Authors:  Richard Wassersug; Erik Wibowo
Journal:  Transl Androl Urol       Date:  2017-11

5.  Feasibility of an intervention for men on androgen deprivation therapy: A research protocol.

Authors:  Alana Manson; Jamie Myers; Sandra Billinger; Jaimie Ward; William Parker; Jill Hamilton-Reeves; Carrie Michel; Sally L Maliski
Journal:  Res Nurs Health       Date:  2019-08-07       Impact factor: 2.228

6.  TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial.

Authors:  D Wittmann; A Mehta; L Northouse; R Dunn; T Braun; A Duby; L An; L Arab; R Bangs; S Bober; J Brandon; M Coward; M Dunn; M Galbraith; M Garcia; J Giblin; M Glode; B Koontz; A Lowe; S Mitchell; J Mulhall; C Nelson; K Paich; C Saigal; T Skolarus; J Stanford; T Walsh; C E Pollack
Journal:  BMC Cancer       Date:  2017-10-02       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.